Genpact Ltd’s filing revealed that its Director Gangestad Nicholas C acquired Company’s shares for reported $87940.0 on May 13 ’25. In the deal valued at $43.97 per share,2,000 shares were bought. As a result of this transaction, Gangestad Nicholas C now holds 2,000 shares worth roughly $90640.0.
Then, Kalra Balkrishan sold 13,600 shares, generating $664,904 in total proceeds. Upon selling the shares at $48.89, the President and CEO now owns 310,246 shares.
Before that, BALKRISHAN KALRA bought 13,600 shares. Genpact Ltd shares valued at $664,956 were divested by the Officer at a price of $48.89 per share.
A number of analysts have revised their coverage, including TD Cowen’s analysts, who increased its forecast for the stock in early February from “a Hold” to “a Buy”. Jefferies also remained covering G and has increased its forecast on January 21, 2025 with a “Buy” recommendation from previously “Hold” rating. JP Morgan revised its rating on July 17, 2024. It rated G as “a Neutral” which previously was an “an Underweight”.
Price Performance Review of G
On Monday, Genpact Ltd [NYSE:G] saw its stock fall -0.42% to $45.32. Over the last five days, the stock has gained 0.94%. Genpact Ltd shares have risen nearly 35.20% since the year began. Nevertheless, the stocks have risen 5.52% over the past one year. While a 52-week high of $56.76 was reached on 02/07/25, a 52-week low of $32.18 was recorded on 05/08/25.
Levels Of Support And Resistance For G Stock
The 24-hour chart illustrates a support level at 45.10, which if violated will result in even more drops to 44.89. On the upside, there is a resistance level at 45.52. A further resistance level may holdings at 45.73.
How much short interest is there in Genpact Ltd?
A steep rise in short interest was recorded in Genpact Ltd stocks on 2025-07-15, growing by 1.01 million shares to a total of 6.94 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 5.93 million shares. There was a rise of 14.55%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 30, 2024 when Mizuho began covering the stock and recommended ‘”a Neutral”‘ rating along with a $40 price target.
